Alectinib treatment improves photodynamic therapy in cancer cell lines of different origin

BACKGROUND: Photodynamic therapy with a photosensitizer such as protoporphyrin-IX, a light sensitive metabolite of heme synthesis, is a highly selective treatment for various carcinomas. In previous studies, we found a significant down regulation of the relevant enzyme ferrochelatase in gastrointest...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillissen, Bernhard, Richter, Antje, Essmann, Frank, Kemmner, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404354/
https://www.ncbi.nlm.nih.gov/pubmed/34461853
http://dx.doi.org/10.1186/s12885-021-08667-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404354/
https://www.ncbi.nlm.nih.gov/pubmed/34461853
http://dx.doi.org/10.1186/s12885-021-08667-x

Ejemplares similares